Banlangen Injection

Keywords:

Product News

Banlangen Injection


Advanced controlled-release technology: Bioavailability reaches as high as 99.6%. Thixotropic colloidal technology ensures excellent drug stability and prevents degradation. The solvent, combined with a unique compound, forms a thixotropic colloid that remains gel-like when stationary—preventing drug particles from clumping—and instantly liquefies upon shaking. This results in outstanding drug fluidity, preventing the medication from sticking to container walls, making it easy to inject and readily absorbed by the body. Additionally, the formulation exhibits minimal irritation, significantly reducing injection-related stress. Leveraging this innovative technology, drug particles are uniformly dispersed within the thixotropic colloid, ensuring long-term stability of the particle state.